Search Orphan Drug Designations and Approvals
-
| Generic Name: | Maytansine bound via linker to bacterial derived, negatively charged modified Gyrase inhibitor |
|---|---|
| Date Designated: | 07/25/2023 |
| Orphan Designation: | Treatment of Glioblastoma Multiforme |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
CyGenica Ltd. Unit 4 Joyce House, Barrack Square Ballincollig, County Cork P31 HW35 Ireland The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







